Connect with us

News

Marijuana Retail Report

Published

on

Marijuana Retail Report



“We are working to create a market that is controlled, regulated and responsible”

Five years after Virginia legalized simple possession of adult marijuana, lawmakers are deadlocked on how to finally create a legal retail market after the General Assembly last week rejected more than 40 changes proposed by Gov. Abigail Spanberger and sent the legislation back to her desk.

The move leaves Spanberger with a binary choice: Sign the long-discussed proposal to launch retail sales, or veto it and prolong a years-long stalemate that has left Virginia in a legal gray area where cannabis is legal to possess but not legally to buy.

The deputy governorwhich disappointed many lawmakers and stakeholders, would delay the latest start of retail sales until July 1, 2027, while restructuring much of the legislative framework were negotiating during the session.

“Five years ago, the commonwealth took the first steps to legalize marijuana — and for five years, the job remained unfinished,” Spanberger said in a statement.

To read the rest of this article on WTOP, Click here

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Indiana

Marijuana Retail Report

Published

on

By

Marijuana Retail Report



The conversation took place at the Indiana Department of Veterans Affairs

On Friday morning, the meeting in the village was in the center of attention Indiana The Department of Veterans Affairs turned out to be medical marijuana.

The conversation between veteran Hoosiers for Medical Cannabis, Indiana NORML, and state agency leaders was planned about a month ago, but it came a day after the acting U.S. attorney general signed an order reclassifying state-licensed medical marijuana as a less dangerous drug.

Medical marijuana was reclassified from a Schedule I drug — a high-abuse, non-medical category of Schedule III drugs like heroin and cocaine — with less addictive drugs like prescription Tylenol.

“You have to understand that a lot of our state legislators have been waiting for this,” said veteran Jeff Staker. “The feds have made their move, and now it’s time for Indiana to make ours. And of course, we want to do it right.”

Staker has pushed for medical marijuana legislation for 10 years, arguing that it is a safer alternative to opioid painkillers prescribed to veterans for PTSD and chronic pain.

To read the rest of this article on WTHR, Click here

Continue Reading

Best Practices

Marijuana Retail Report

Published

on

By

Marijuana Retail Report



The DEA dispensary application portal is now live

For state-licensed medical marijuana operators, a narrow and potentially transformative window has opened that could position your business for future interstate and even global commerce.

While acting as the Prosecutor General rezoning order likely to face legal challenges, the immediate reality is that you have 60 days to act. As of yesterday, April 28, holders of state medical marijuana licenses can apply for DEA registration to manufacture (this includes cultivation and limited processing), distribute, and dispense medical marijuana.

DEA dispensary application portal is already operational and production and distribution applications are expected to comply with the standard DEA Form 225 Process.

We are not sure whether this framework would stand up to trialand if so, to what extent. However, it is clear that only those applicants who apply within this initial 60-day window are eligible for expedited review, which must take place within six months of application. The transfer order does not provide guidance on future application rounds or deadlines, leaving considerable uncertainty for those waiting.

In practical terms, this creates a first-mover advantage. If DEA registration ends up being the gateway to a federally recognized and possibly global market for medical cannabis, early applicants will have the best opportunity to participate.

We describe it as a “lottery ticket” not because it is speculative, but because it requires an upfront investment with uncertain outcomes. Retaining experienced counsel and preparing the relevant application typically costs in the range of $10,000 to $15,000 (including DEA fees), with additional costs depending on the complexity, scope and number of DEA filings required. The bet is $10,000 to $15,000 on a potential growth opportunity of hundreds of thousands or millions of dollars.

For those who are ready to move forward, we can help navigate the process effectively and strategically. Our team is one of the few with DEA ​​registration experience. We can:

  • Provide a clear overview of the DEA registration system and historical precedents
  • Prepare you for possible follow-up DEA inquiries and requests for additional information
  • Assistance in completing and submitting your application
  • Develop a comprehensive support package to strengthen your submission when the DEA seeks additional information
  • Advise on international treaty obligations and operational compliance considerations referenced by the order

If you plan to register with the DEA during this period, we encourage you to connect with our team to discuss your options. We are ready to provide you with a free consultation and help you evaluate whether this opportunity fits your business strategy.

Source: Legal Canna Blog

Continue Reading

News

Marijuana Retail Report

Published

on

By

Marijuana Retail Report



“DEA registration marks a historic step forward for our medical business”

TALLAHASSEE, FL, April 29, 2026 /PRNewswire/ — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or the “Company”), the leading and most effective cannabis company in the United States, today announced that it has filed applications with the U.S. Drug Enforcement Administration (DEA) to register certain state-licensed medical marijuana operations under the expedited registration pathway established by the recent transfer of medical marijuana to Schedule III under the Controlled Substances Act.

“Dea registration for our healthcare business marks a historic step forward for Trulieve and the patients we serve,” said Trulieve Chief Executive Officer Kim Rivers. “With more than 200 medical-only dispensaries, Trulieve is uniquely positioned to set the bar for a responsible operator in the US.”

Following the reclassification of medical marijuana to Schedule III, the DEA established an expedited registration process for eligible state-licensed medical marijuana operators. For operators who have applied within 60 days, a license to manufacture, distribute and dispense Schedule III marijuana medical products is deemed approved unless otherwise noted.

About Truliev
Trulieve is an industry-leading vertically integrated cannabis company and multi-state operator in the US with established hubs in the Northeast, Southeast and Southwest, anchored by corner markets in Arizona, Florida, Ohio and Pennsylvania. Driven by the core mission of expanding access to cannabis, Trulieve offers customers innovative, high-quality branded products and an exceptional experience. With large-scale operations in attractive markets and targeted expansion through a hub strategy, Trulieve is poised for accelerated growth. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve
X: @Trulieve

Investor and media contacts
Christine Hersey, Chief Corporate Affairs and Strategy Officer
+1 (424) 202-0210
(email protected)

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media